BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leung L. Cannabis and its derivatives: review of medical use. J Am Board Fam Med. 2011;24:452-462. [PMID: 21737770 DOI: 10.3122/jabfm.2011.04.100280] [Cited by in Crossref: 56] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Rehm J, Crépault JF, Fischer B. The Devil Is in the Details! On Regulating Cannabis Use in Canada Based on Public Health Criteria Comment on "Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts". Int J Health Policy Manag 2017;6:173-6. [PMID: 28812798 DOI: 10.15171/ijhpm.2016.114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
2 Wilson-Morkeh H, Al-Abdulla A, Sien L, Mohamed H, Youngstein T. Important drug interactions exist between cannabidiol oil and commonly prescribed drugs in rheumatology practice. Rheumatology (Oxford) 2020;59:249-51. [PMID: 31359066 DOI: 10.1093/rheumatology/kez304] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
3 Pacula RL, Kilmer B, Wagenaar AC, Chaloupka FJ, Caulkins JP. Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am J Public Health 2014;104:1021-8. [PMID: 24825201 DOI: 10.2105/AJPH.2013.301766] [Cited by in Crossref: 142] [Cited by in F6Publishing: 42] [Article Influence: 20.3] [Reference Citation Analysis]
4 Kapur BM, Lala PK, Shaw JL. Pharmacogenetics of chronic pain management. Clin Biochem 2014;47:1169-87. [PMID: 24912048 DOI: 10.1016/j.clinbiochem.2014.05.065] [Cited by in Crossref: 63] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
5 Richardson KA, Hester AK, McLemore GL. Prenatal cannabis exposure - The "first hit" to the endocannabinoid system. Neurotoxicol Teratol 2016;58:5-14. [PMID: 27567698 DOI: 10.1016/j.ntt.2016.08.003] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
6 Calvi L, Pentimalli D, Panseri S, Giupponi L, Gelmini F, Beretta G, Vitali D, Bruno M, Zilio E, Pavlovic R, Giorgi A. Comprehensive quality evaluation of medical Cannabis sativa L. inflorescence and macerated oils based on HS-SPME coupled to GC–MS and LC-HRMS (q-exactive orbitrap®) approach. Journal of Pharmaceutical and Biomedical Analysis 2018;150:208-19. [DOI: 10.1016/j.jpba.2017.11.073] [Cited by in Crossref: 54] [Cited by in F6Publishing: 33] [Article Influence: 18.0] [Reference Citation Analysis]
7 Sagy I, Peleg-sagy T, Barski L, Zeller L, Jotkowitz A. Ethical issues in medical cannabis use. European Journal of Internal Medicine 2018;49:20-2. [DOI: 10.1016/j.ejim.2018.01.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Boehnke KF, Litinas E, Clauw DJ. Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. J Pain 2016;17:739-44. [PMID: 27001005 DOI: 10.1016/j.jpain.2016.03.002] [Cited by in Crossref: 181] [Cited by in F6Publishing: 117] [Article Influence: 36.2] [Reference Citation Analysis]
9 Fischer B, Murphy Y, Kurdyak P, Goldner E, Rehm J. Medical marijuana programs - Why might they matter for public health and why should we better understand their impacts? Prev Med Rep 2015;2:53-6. [PMID: 26844050 DOI: 10.1016/j.pmedr.2014.12.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Gao S, Wang B, Xie S, Xu X, Zhang J, Pei L, Yu Y, Yang W, Zhang Y. A high-quality reference genome of wild Cannabis sativa. Hortic Res 2020;7:73. [PMID: 32377363 DOI: 10.1038/s41438-020-0295-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 20.0] [Reference Citation Analysis]
11 Rezkalla S, Kloner RA. Recreational marijuana use: is it safe for your patient? J Am Heart Assoc 2014;3:e000904. [PMID: 24760963 DOI: 10.1161/JAHA.114.000904] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cox C. The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018. Health Policy 2018;122:205-9. [DOI: 10.1016/j.healthpol.2018.01.009] [Cited by in Crossref: 44] [Cited by in F6Publishing: 22] [Article Influence: 14.7] [Reference Citation Analysis]
13 Pedersen W. From badness to illness: Medical cannabis and self-diagnosed attention deficit hyperactivity disorder. Addiction Research & Theory 2014;23:177-86. [DOI: 10.3109/16066359.2014.954556] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
14 Burggren AC, Shirazi A, Ginder N, London ED. Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives. Am J Drug Alcohol Abuse 2019;45:563-79. [PMID: 31365275 DOI: 10.1080/00952990.2019.1634086] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
15 Perisetti A, Rimu AH, Khan SA, Bansal P, Goyal H. Role of cannabis in inflammatory bowel diseases. Ann Gastroenterol 2020;33:134-44. [PMID: 32127734 DOI: 10.20524/aog.2020.0452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
16 Ciccone CD. Medical Marijuana: Just the Beginning of a Long, Strange Trip? Phys Ther 2017;97:239-48. [PMID: 27660328 DOI: 10.2522/ptj.20160367] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
17 Kuhlen M, Hoell JI, Gagnon G, Balzer S, Oommen PT, Borkhardt A, Janßen G. Effective treatment of spasticity using dronabinol in pediatric palliative care. European Journal of Paediatric Neurology 2016;20:898-903. [DOI: 10.1016/j.ejpn.2016.07.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
18 Fine PG, Rosenfeld MJ. The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Med J 2013;4:e0022. [PMID: 24228165 DOI: 10.5041/RMMJ.10129] [Cited by in Crossref: 72] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
19 Deng L, Guindon J, Vemuri VK, Thakur GA, White FA, Makriyannis A, Hohmann AG. The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy. Mol Pain 2012;8:71. [PMID: 22998838 DOI: 10.1186/1744-8069-8-71] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 7.0] [Reference Citation Analysis]
20 Pavlovic R, Nenna G, Calvi L, Panseri S, Borgonovo G, Giupponi L, Cannazza G, Giorgi A. Quality Traits of "Cannabidiol Oils": Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations. Molecules 2018;23:E1230. [PMID: 29783790 DOI: 10.3390/molecules23051230] [Cited by in Crossref: 65] [Cited by in F6Publishing: 34] [Article Influence: 21.7] [Reference Citation Analysis]
21 Peschel W. Quality Control of Traditional Cannabis Tinctures: Pattern, Markers, and Stability. Sci Pharm 2016;84:567-84. [PMID: 28117322 DOI: 10.3390/scipharm84030567] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
22 Śledziński P, Nowak-Terpiłowska A, Zeyland J. Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases. Int J Mol Sci 2020;22:E263. [PMID: 33383838 DOI: 10.3390/ijms22010263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Argoff CE, Alford DP, Fudin J, Adler JA, Bair MJ, Dart RC, Gandolfi R, McCarberg BH, Stanos SP, Gudin JA, Polomano RC, Webster LR. Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations. Pain Med 2018;19:97-117. [PMID: 29206984 DOI: 10.1093/pm/pnx285] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 14.5] [Reference Citation Analysis]
24 Pedersen W, Sandberg S. The medicalisation of revolt: a sociological analysis of medical cannabis users: Medical cannabis users. Sociology of Health & Illness 2013;35:17-32. [DOI: 10.1111/j.1467-9566.2012.01476.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
25 Aviram J, Lewitus GM, Pud D, Procaccia S, Berman P, Yellin B, Vysotski Y, Hazan O, Eisenberg E, Meiri D. Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis. Pharmacol Res 2021;169:105651. [PMID: 34000362 DOI: 10.1016/j.phrs.2021.105651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Jehle CC Jr, Nazir N, Bhavsar D. The rapidly increasing trend of cannabis use in burn injury. J Burn Care Res 2015;36:e12-7. [PMID: 25412052 DOI: 10.1097/BCR.0000000000000192] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
27 Collen M. Prescribing cannabis for harm reduction. Harm Reduct J 2012;9:1. [PMID: 22208773 DOI: 10.1186/1477-7517-9-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
28 Cherniakov I, Izgelov D, Barasch D, Davidson E, Domb AJ, Hoffman A. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration. Journal of Controlled Release 2017;266:1-7. [DOI: 10.1016/j.jconrel.2017.09.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
29 Delisi LE, Fleischhacker WW. The problem of substance abuse in people with schizophrenia. Current Opinion in Psychiatry 2015;28:199-200. [DOI: 10.1097/yco.0000000000000150] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 2013;33:195-209. [PMID: 23386598 DOI: 10.1002/phar.1187] [Cited by in Crossref: 272] [Cited by in F6Publishing: 179] [Article Influence: 34.0] [Reference Citation Analysis]
31 Luquiens A, Lourenco N, Benyamina A, Aubin HJ. Self-medication of achalasia with cannabis, complicated by a cannabis use disorder. World J Gastroenterol 2015;21:6381-3. [PMID: 26034374 DOI: 10.3748/wjg.v21.i20.6381] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
32 Powell D, Pacula RL, Jacobson M. Do medical marijuana laws reduce addictions and deaths related to pain killers? J Health Econ 2018;58:29-42. [PMID: 29408153 DOI: 10.1016/j.jhealeco.2017.12.007] [Cited by in Crossref: 135] [Cited by in F6Publishing: 80] [Article Influence: 45.0] [Reference Citation Analysis]
33 Richmond MK, Page K, Rivera LS, Reimann B, Fischer L. Trends in detection rates of risky marijuana use in Colorado health care settings. Subst Abus 2013;34:248-55. [PMID: 23844955 DOI: 10.1080/08897077.2012.755146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
34 Michaels TI, Purdon J, Collins A, Williams MT. Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature. BMC Psychiatry 2018;18:245. [PMID: 30064392 DOI: 10.1186/s12888-018-1824-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 10.3] [Reference Citation Analysis]